Rare diseases
Investigational molecules
Locations
Back to Italy81 clinical trials in Cuneo, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)ItalyStudy on Fianlimab and Cemiplimab for Adults with Resectable Stage III and IV Melanoma
ItalyStudy on Ponatinib and Blinatumomab for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
ItalyStudy of Ibrutinib and Rituximab for Patients with Follicular Lymphoma
ItalyStudy of Daratumumab with Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Eligible for High-Dose Therapy
ItalyStudy on Ravulizumab for Patients with Thrombotic Microangiopathy After Stem Cell Transplant
ItalyStudy of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma
ItalyStudy on the Effects of Dersimelagon Phosphate for Adults and Adolescents with Erythropoietic Protoporphyria or X-Linked Protoporphyria
ItalyStudy on Atezolizumab for Patients with Non-Small Cell Lung Cancer After Chemotherapy
ItalyStudy of Selinexor, Ifosfamide, Etoposide, and Dexamethasone for Patients with Relapsed or Refractory Peripheral T-cell Lymphomas
ItalyStudy of pirtobrutinib, venetoclax and rituximab combination compared to venetoclax and rituximab in previously treated Chronic Lymphocytic Leukemia patients
ItalyStudy on the Safety and Anti-tumor Effects of GEN1042 Alone or with Pembrolizumab and Chemotherapy in Patients with Advanced Solid Tumors
ItalyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking trials focusing on Acute Myeloid Leukemia (AML) and various lymphomas, testing innovative combination therapies and transplantation approaches.
Studies evaluating targeted therapies for Multiple Myeloma and Chronic Lymphocytic Leukemia.
Research examining innovative treatments for breast cancer, including trials for triple-negative and hormone-responsive subtypes.
Advanced studies in ovarian cancer and lung cancer, exploring novel therapeutic approaches.
Investigating immunotherapy approaches across multiple cancer types, with focus on combination strategies.
Evaluation of novel drug combinations and treatment sequences for optimal patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
